How COVID-19 is revealing the Latinx healthcare gap
26 Apr 2021
How COVID-19 is revealing the Latinx healthcare gap

COVID-19 hit America’s Latinx population hard, and despite being one of the fastest-growing ethnic groups, they’ve been underrepresented in both clinical trials and rollout campaigns for the vaccine. So, how can brands in the pharma/healthcare space better accommodate these audiences?

Daniel Guerra Jr.

Daniel Guerra Jr. is the CEO and founder of AltusLearn Network, a platform that enables healthcare professionals to track and meet annual compliance requirements. Before starting AltusLearn, he owned and managed technology companies for 15 years, covering web development to e-commerce. He’s now working to ameliorate information gaps that minorities face in the healthcare system.

Dr. Rena Conti

Dr. Rena Conti is the associate research director of biopharma and public policy for the Boston University Institute for Health System Innovation and Policy. Her research focuses on the organization, financing, and regulation of medical care. She has written extensively on the pricing, demand, and supply of prescription drugs.

Dr. Shikha Jain

Dr. Shikha Jain is a board-certified hematology and oncology physician. She is an assistant professor of medicine in the Division of Hematology and Oncology at the University of Illinois Cancer Center. She is also the director of communication strategies in medicine and the associate director of oncology communication and digital innovation.

Andres Zambrano Bravo

Andres Zambrano Bravo is a Berlin-based freelance journalist who loves to ask why. He loves puzzles and seeks answers to social phenomena and trends, helping researchers, companies, and artists to also find their voice along the way. When not annoying people with questions, you can find him spinning records in one of Berlin’s smoky venues.